Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Motus Gi Holdings Inc (MOTS)

Motus Gi Holdings Inc (MOTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 245
  • Shares Outstanding, K 5,769
  • Annual Sales, $ 320 K
  • Annual Income, $ -12,870 K
  • 60-Month Beta 1.81
  • Price/Sales 1.13
  • Price/Cash Flow N/A
  • Price/Book 0.11
Trade MOTS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -14.69
  • Most Recent Earnings $-0.88 on 05/14/24
  • Next Earnings Date 08/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -5.40
  • Growth Rate Est. (year over year) +18,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0315 +34.60%
on 06/17/24
0.1860 -77.20%
on 06/03/24
-0.1376 (-76.44%)
since 05/31/24
3-Month
0.0315 +34.60%
on 06/17/24
0.4731 -91.04%
on 04/10/24
-0.4076 (-90.58%)
since 04/02/24
52-Week
0.0315 +34.60%
on 06/17/24
11.0790 -99.62%
on 07/21/23
-10.0076 (-99.58%)
since 06/30/23

Most Recent Stories

More News
Motus GI Announces 1-FOR-20 Reverse Stock Split

FORT LAUDERDALE, Fla., July 25, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0424 (-15.20%)
Motus GI to Release Second Quarter Results and Provide a Business Update on August 11

FORT LAUDERDALE, Fla., July 21, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0424 (-15.20%)
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System in Hard-to-Prepare Patients Presented at Digestive Disease Week 2022

– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of poor bowel preparation FORT LAUDERDALE,...

MOTS : 0.0424 (-15.20%)
Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update

Pure-Vu EVS approved for use at 11 hospitals since product launch commenced in March 2022; with strong procedural volumes and significant positive feedback...

MOTS : 0.0424 (-15.20%)
Motus GI to Release First Quarter Results and Provide a Business Update on May 12

FORT LAUDERDALE, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0424 (-15.20%)
Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Received FDA clearance in February 2022 to market Pure-Vu EVS, an all new, next-generation system that has been deployed to multiple hospitals in the first...

MOTS : 0.0424 (-15.20%)
Motus GI to Release Fourth Quarter and Full Year 2021 Results and Provide a Business Update on March 29

FORT LAUDERDALE, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0424 (-15.20%)
Motus GI to Participate in Two Upcoming Investor Conferences in March 2022

FORT LAUDERDALE, Fla., March 02, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology...

MOTS : 0.0424 (-15.20%)
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System

-All New Pure-Vu EVS offers rapid set-up, improved navigation and enhanced cleansing capabilities to support expanded clinical utilization -Scientific...

MOTS : 0.0424 (-15.20%)
Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features

Expanding patent portfolio extends first-mover advantage in the colonoscopy procedure market, estimated at close to 55M global procedures per year...

MOTS : 0.0424 (-15.20%)

Business Summary

Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also...

See More

Key Turning Points

3rd Resistance Point 0.0743
2nd Resistance Point 0.0674
1st Resistance Point 0.0549
Last Price 0.0424
1st Support Level 0.0355
2nd Support Level 0.0286
3rd Support Level 0.0161

See More

52-Week High 11.0790
Fibonacci 61.8% 6.8589
Fibonacci 50% 5.5553
Fibonacci 38.2% 4.2516
Last Price 0.0424
52-Week Low 0.0315

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar